Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description significantly expands on the annotations by disclosing soft-fail behavior ('USPTO PatentsView API sunset May 2025 — soft-fails until reactivated'), expected empty results for fda_products when a company has only small-molecule drugs, and the semantics of sources_used/sources_failed ('an empty section is a real "no data", not a bug'). It also documents resolved_from/resolved_to and resolved:false for private companies, all consistent with the readOnly/idempotent hints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but every clause contributes meaning—covering sources, return fields, failure modes, and routing. It is front-loaded with query examples and the 'ALWAYS PREFER' directive. The semicolon-heavy structure is dense but scannable; a more segmented layout would improve readability, though nothing is redundant.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Since there is no output schema, the description carries the burden of enumerating return fields (cik, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/failed). It also covers data-source quirks, failure modes, and edge cases, making it fully self-sufficient for an agent to select and invoke correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

While schema coverage is 100%, the description adds valuable nuance: `type` values 'company' and 'ticker' are explicitly interchangeable and accept the same `value` shapes, and `value` can be a ticker, zero-padded CIK, or company name resolved via SEC EDGAR. This clarifies edge cases and reduces the chance of an agent passing the wrong type or format.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user queries ('Tell me about X', 'research Acme') and immediately states the core function: 'full cross-source profile of a US public company in ONE parallel call.' This is a specific verb+resource+scope that clearly differentiates it from chained single-source lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit routing rule: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also specifies accepted inputs (ticker, CIK, or name), how names resolve, and what happens for private companies, giving the agent enough context to decide when this tool is appropriate.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Several clusters overlap: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near variants (beta currently identical), and the prediction-market tools share adjacent territory. The descriptions do delineate most use cases, but an agent could easily confuse the ask_pipeworx variants or pick between polymarket_edges and bet_research.

Naming Consistency2/5

Naming is a mix of domain-prefixed verbs (data360_get_data, pipeworx_feedback), bare verbs (forget, recall, subscribe), and noun phrases (entity_profile, recent_changes, polymarket_edges). The ask_pipeworx family is consistent, but there is no server-wide verb_noun convention and tool names are not predictable from their function.

Tool Count2/5

34 tools is too many for a well-scoped server, and the set spans unrelated areas: data retrieval, prediction markets, memory, subscriptions, npm dependency scanning, and llms.txt generation. While each tool has a purpose, the overall surface feels sprawling rather than focused.

Completeness4/5

The core data/research workflows are well covered: ask/grounded/deep research, entity identity and profiles, comparisons, claim validation, and subscription lifecycle management are all present. Minor gaps exist, such as no explicit raw-record fetch tool and some auxiliary features appearing as one-off utilities, but no major dead ends are apparent.